May 7, 2019
Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing
Proceeds will support ongoing clinical evaluation of HepaStem® in ACLF and launch of a clinical trial in late stage NASH…
Pharmaceuticals, Biotechnology and Life Sciences
Proceeds will support ongoing clinical evaluation of HepaStem® in ACLF and launch of a clinical trial in late stage NASH…
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris: SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and…
In the dose-finding Part 1 of FIREFISH, infants with Type 1 spinal muscular atrophy survive and achieve key milestones beyond…
MARIETTA, Ohio–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AAGP?src=hash" target="_blank"gt;#AAGPlt;/agt;–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX) has been requested by OTC Markets Group…
Move reinforces strategic focus on core businesses Consolidated non-GAAP adjusted EBITDA margin expected to increase to approximately 45% from its…
PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva Systems (NYSE:VEEV) will announce financial results for its fiscal first quarter which ended April 30, 2019 after…
Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company (to be…
SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of…
–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CARTCR?src=hash" target="_blank"gt;#CARTCRlt;/agt;–Nuvera Life Science Consulting is a consulting company dedicated to helping the world’s leading pharmaceutical and biotech…